McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century.

Vitamin D is absolutely essential for the maintenance of a healthy skeleton throughout our lives. There is mounting evidence that vitamin D insufficiency and vitamin D deficiency in elderly people is a silent epidemic that results in bone loss and fractures. It is casual exposure to sunlight that provides most humans with their vitamin D requirement. Seasonal changes, time of day, latitude, aging, sunscreen use, and melanin pigmentation can substantially influence the cutaneous production of vitamin D. Although the recommended dietary allowance for vitamin D in adults is 5 micrograms (200 IU), there is mounting evidence that in the absence of exposure to sunlight the vitamin D requirement is at least 15 micrograms (600 IU)/d. The skin is a target tissue for the active form of vitamin D (1,25-dihydroxycholecalciferol). 1,25-Dihydroxycholecalciferol inhibits the proliferation of cultured keratinocytes and induces them to differentiate. 1,25-Dihydroxycholecalciferol and its analogs have been developed as an effective new therapy for the treatment of the hyperproliferative skin disease psoriasis.

[1]  A. Shao,et al.  An update on the vitamin D content of fortified milk from the United States and Canada. , 1993, The New England journal of medicine.

[2]  M. Holick Active vitamin D compounds and analogues: a new therapeutic era for dermatology in the 21st century. , 1993, Mayo Clinic proceedings.

[3]  T. Chen,et al.  Influence of Season and Time of Day on the Synthesis of Vitamin D3 , 1992 .

[4]  M. Holick,et al.  Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. , 1992, The Journal of clinical endocrinology and metabolism.

[5]  J. Brody,et al.  Seasonal variation in the incidence of hip fracture among white persons aged 65 years and older in the United States, 1984-1987. , 1991, American journal of epidemiology.

[6]  D. Felson,et al.  Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study. , 1990, Arthritis and rheumatism.

[7]  M. Holick,et al.  An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. , 1990, The American journal of clinical nutrition.

[8]  M. Holick Vitamin D and the skin: photobiology, physiology and therapeutic efficacy for psoriasis , 1990 .

[9]  B. Dawson-Hughes,et al.  Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women , 1989, The New England journal of medicine.

[10]  M. Holick,et al.  Will 1,25-dihydroxyvitamin D3, MC 903, and their analogues herald a new pharmacologic era for the treatment of psoriasis? , 1989, Archives of dermatology.

[11]  M. Holick,et al.  AGE, VITAMIN D, AND SOLAR ULTRAVIOLET , 1989, The Lancet.

[12]  M. Holick 1,25-Dihydroxyvitamin D3 and the Skin: A Unique Application for the Treatment of Psoriasis , 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  M. Holick,et al.  Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. , 1989, The Journal of clinical endocrinology and metabolism.

[14]  H. Koeffler,et al.  The role of the vitamin D endocrine system in health and disease. , 1989, The New England journal of medicine.

[15]  T. Kuroki,et al.  Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin. , 1989, The Journal of clinical endocrinology and metabolism.

[16]  M. Holick,et al.  Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. , 1988, Archives of dermatology.

[17]  P. Delmas,et al.  The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. , 1988, The Journal of clinical endocrinology and metabolism.

[18]  M. Holick,et al.  A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis. , 1988, Journal of the American Academy of Dermatology.

[19]  M. Holick,et al.  Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. , 1988, The Journal of clinical endocrinology and metabolism.

[20]  H. DeLuca The vitamin D story: a collaborative effort of basic science and clinical medicine 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  M. Holick,et al.  Sunscreens suppress cutaneous vitamin D3 synthesis. , 1987, The Journal of clinical endocrinology and metabolism.

[22]  T. Clemens,et al.  Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. , 1986, The Journal of clinical endocrinology and metabolism.

[23]  N. Walworth,et al.  Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions , 1986 .

[24]  M. Holick Vitamin D requirements for the elderly , 1986 .

[25]  M. Holick,et al.  Aging decreases the capacity of human skin to produce vitamin D3. , 1985, The Journal of clinical investigation.

[26]  S. Epstein,et al.  Evidence for alteration of the vitamin D-endocrine system in blacks. , 1985, The Journal of clinical investigation.

[27]  M. Holick,et al.  Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Z. Hochberg,et al.  Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. , 1982, The Journal of clinical endocrinology and metabolism.

[29]  P. Payne,et al.  Skin thickness measurement by pulsed ultrasound; its reproducibility, validation and variability , 1982, The British journal of dermatology.

[30]  J. Adams,et al.  INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.

[31]  D. Feldman,et al.  1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. , 1981, Endocrinology.

[32]  M. Holick,et al.  Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. , 1981, Science.

[33]  R. Anderson,et al.  Photosynthesis of previtamin D3 in human skin and the physiologic consequences. , 1980, Science.

[34]  H. DeLuca,et al.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. , 1979, Science.

[35]  W. Loomis Skin-Pigment Regulation of Vitamin-D Biosynthesis in Man , 1967, Science.

[36]  J. Chalmers,et al.  Osteomalacia--a common disease in elderly women. , 1967, The Journal of bone and joint surgery. British volume.

[37]  J. Mayer,et al.  Armand Trousseau and the arrow of time. , 2009, Nutrition reviews.

[38]  A. Hess,et al.  ANTIRACHITIC PROPERTIES IMPARTED TO INERT FLUIDS AND TO GREEN VEGETABLES BY ULTRA-VIOLET IRRADIATION , 1924 .

[39]  H. Steenbock THE INDUCTION OF GROWTH PROMOTING AND CALCIFYING PROPERTIES IN A RATION BY EXPOSURE TO LIGHT. , 1924, Science.

[40]  H. Steenbock,et al.  FAT-SOLUBLE VITAMINS XVII. THE INDUCTION OF GROWTH-PROMOTING AND CALCIFYING PROPERTIES IN A RATION BY EXPOSURE TO ULTRA-VIOLET LIGHT , 1924 .

[41]  E. V. Mccollum,et al.  STUDIES ON EXPERIMENTAL RICKETS XXI. AN EXPERIMENTAL DEMONSTRATION OF THE EXISTENCE OF A VITAMIN WHICH PROMOTES CALCIUM DEPOSITION , 1922 .

[42]  Sir Edward Mellanby The part played by an accessory factor in the production of experimental rickets. , 1918 .